tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Madrigal Pharmaceuticals price target raised to $745 from $527 at Citizens
PremiumThe FlyMadrigal Pharmaceuticals price target raised to $745 from $527 at Citizens
25d ago
Madrigal Pharmaceuticals price target raised to $644 from $554 at TD Cowen
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $644 from $554 at TD Cowen
1M ago
Madrigal: Expanding MASH Franchise and Combination Therapy Strategy Drive Raised Price Target and Reaffirmed Buy Rating
Premium
Ratings
Madrigal: Expanding MASH Franchise and Combination Therapy Strategy Drive Raised Price Target and Reaffirmed Buy Rating
1M ago
These Are the Most and Least Likely Biotech Takeover Targets for 2026
PremiumMarket NewsThese Are the Most and Least Likely Biotech Takeover Targets for 2026
2M ago
Short Report: Vera Therapeutics bears retreat as stock rallies
Premium
The Fly
Short Report: Vera Therapeutics bears retreat as stock rallies
2M ago
Madrigal Pharmaceuticals price target raised to $900 from $540 at Piper Sandler
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $900 from $540 at Piper Sandler
2M ago
Strong Adoption and Market Expansion Drive Buy Rating for Madrigal Pharmaceuticals’ Rezdiffra
PremiumRatingsStrong Adoption and Market Expansion Drive Buy Rating for Madrigal Pharmaceuticals’ Rezdiffra
3M ago
Madrigal price target raised to $620 from $568 at H.C. Wainwright
Premium
The Fly
Madrigal price target raised to $620 from $568 at H.C. Wainwright
3M ago
Madrigal Pharmaceuticals price target raised to $650 from $600 at Oppenheimer
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $650 from $600 at Oppenheimer
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100